SS Innovations International Inc. (SSII)
NASDAQ: SSIIHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SSII stock chart
Technical analysisKey statistics
All statistics- Market cap
- $254.86M
- EPS (TTM)
- -$0.07
- Dividend yield
- None
- 52-week range
- 1.12 – 6.79
- Day range
- 1.25 – 1.46
- Volume / Avg
- 94.33K / 86.18K
- Beta
- —
- Shares outstanding
- 200.68M
52-week range
SSII stock today
On Nov 20, SSII ended the session at $1.27, shedding $0.01 (0.78%), versus the S&P 500's 3.70% decline. At this level, SSII sits near the bottom of its 52-week range of $1.12 to $6.79: 81.3% below the high, set on Nov 28, 2025 and 13.4% above the low. SSII is down 77.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 78.7%.
SS Innovations International has posted a net loss over the last twelve months (EPS of -$0.07), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About SS Innovations International
Company profileSS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Dr. Sudhir Prem Srivastava M.D.
- Headquarters
- Gurugram
- Employees
- 483
- Website
- ssinnovations.com
Financial highlights
Full financialsIn fiscal 2025, SS Innovations International generated $42.5 million in revenue, up 105.7% from fiscal 2024, its 3rd consecutive year of revenue growth. SS Innovations International reported a net loss of $12.1 million, compared with a loss of $19.2 million a year earlier. Gross margin was 46.0% (up from 40.9%) and operating margin -19.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $42.48M | $20.65M | $5.88M | $1.44M | — |
| Growth | +105.74% | +251.46% | +309.10% | — | — |
| Net income | $-12.13M | $-19.15M | $-20.88M | $-3.21M | $-1.48M |
| EPS (diluted) | $-0.06 | $-0.11 | $-0.14 | $-0.03 | $-0.05 |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$7.00+451.18%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 17, 2026
- EPS actual vs est.
- $-0.02 vs —
SSII news
All SSII news- SS Innovations International, Inc. Announces World’s First Dual-Console, Beating-Heart TECAB Surgery Utilizing All Five Arms of the SSi Mantra Surgical Robotic SystemNasdaqSSII, UHAL.B
- SS Innovations Announces World’s First Dual-Console, Beating-Heart TECAB Surgery Utilizing All Five Arms of the SSi Mantra Surgical Robotic SystemGlobeNewswire
- SS Innovations International, Inc. CEO Purchases 100,000 Shares of Common Stock in Exchange for $300,000 of Accrued CompensationNasdaq
- SS Innovations Strengthens Management Team in Preparation for Global Sales ExpansionGlobeNewswire
- SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 ConferencesGlobeNewswire
- SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi MantraGlobeNewswire
SS Innovations International peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OFIXOrthofix Medical Inc. | 6.07 | -4.26% | $247.41M | vs SSII |
| NPCENeuropace Inc. | 7.95 | -2.33% | $273.89M | vs SSII |
| OSUROraSure Technologies Inc. | 3.46 | -4.16% | $238.90M | vs SSII |
| PROFProfound Medical Corp. | 6.38 | -3.19% | $233.68M | vs SSII |
| TMCITreace Medical Concepts Inc. | 4.31 | -0.92% | $282.56M | vs SSII |
| INFUInfuSystems Holdings Inc. | 14.35 | +2.06% | $287.48M | vs SSII |
| CLPTClearPoint Neuro Inc. | 6.91 | -5.47% | $221.49M | vs SSII |
| KTWOK2 Capital Acquisition Corporation Class A | 10.13 | 0.00% | $203.02M | vs SSII |
Indexes, lists and sector
SS Innovations International stock FAQ
What is SS Innovations International's stock price today?
SSII last traded at $1.27 as of Nov 20, 4:00 PM EST, down 0.78% on the day. Prices are delayed at least 15 minutes.
Who is SS Innovations International's CEO?
Dr. Sudhir Prem Srivastava M.D. is the chief executive officer of SS Innovations International Inc., which has about 483 employees.
What is the SSII 52-week high?
The 52-week high for SSII is $6.79 and the 52-week low is $1.12. The stock is currently 81.3% below its high.